Stock Market Overview
Stocks Finish Higher on Strength in Tech Earnings
The S&P 500 Index ($SPX) (SPY) Friday closed up +0.41%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.69%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.72%.
Stocks on Friday settled moderately higher on some positive corporate earnings results. Amazon.com closed up more than +6% after forecasting Q4 operating income above consensus. Also, chip stocks rallied on Friday, led by a +7% jump in Intel after it reported better-than-expected Q3 revenue and forecasted Q4 revenue above consensus. Stocks looked past Friday’s weaker-than-expected US payroll and ISM manufacturing reports, as the weakness was due to two hurricanes and labor strikes last month.
On the negative side, Apple closed down more than -1% after reporting Q4 service revenue below consensus and weaker-than-expected China revenue. In addition, Amcor Plc closed down more than -7% after reporting Q1 net sales below consensus. Stock indexes fell back from their best levels Friday after bond... Read more
Nvidia is replacing Intel on the Dow Jones Industrial Average, ending a 25-year-run for a pioneering semiconductor company that has fallen behind as Nvidia cornered the market for chips that run artificial...
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis,...
Barrington analyst Michael Petusky has cut the firm’s price target to $25 from $37
Shares of Shuttle Pharmaceuticals are on the rise following a string of recent developments, including positive updates on its Phase 2 clinical trial, a new $4.5 million public offering and the paying...
Los Angeles County has filed a lawsuit against PepsiCo (PEP) and Coca-Cola (KO), accusing the beverage giants of contributing to plastic pollution and engaging in deceptive business practices. The suit,...
Humacyte (HUMA) experienced a decline of 1.94% in its latest trading session, closing at $5.05, which was slightly more than the S&P 500's 1.86% daily loss. Over the past month, Humacyte's shares have...